Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A form of squamous cell carcinoma in situ. It is a distinct clinicopathological entity and arises from the skin or the mucocutaneous junction. It affects predominantly white males in their 6-8th decades of life. Exposed and non-exposed skin sites are equally affected. UV damage and ingestion of inorganic arsenic may play a role in the development of the disease. On the skin surface, it presents as a single or multiple erythematous, scaly, keratotic patches or plaques. The clinical entity of erythroplasia of Queyrat is regarded as Bowen disease of the penis and it presents as an asymptomatic, red, circumscribed plaque. Morphologically, Bowen disease is characterized by the presence of hyperkeratosis, parakeratosis, dyskeratosis, and acanthosis. The keratotic squamous cells are atypical and display hyperchromatism and abnormal mitotic figures. The dermoepidermal basement membrane is intact. Complete surgical removal of the lesion may be curative.
Biomarker and diagnostic research for Bowen disease of the skin has been reported in the published literature.
1 clinical trial registered. Interventions under study include medical devices and procedural interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
53 publications have been identified in PubMed for Bowen disease of the skin. Research spans Review / Meta-Analysis (30%), Case Report / Case Series (26%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 15 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:37 PM UTC
Common questions about Bowen disease of the skin
Patient case studies | 13 | 26% |
Laboratory research | 7 | 14% |
Testing and diagnosis research | 6 | 12% |
Disease patterns and progression | 5 | 10% |
Clinical study results | 2 | 4% |
Other research | 1 | 2% |
New treatment approaches | 1 | 2% |
Traini DO (2026). [PMID: 41912146](https://pubmed.ncbi.nlm.nih.gov/41912146/). *Dermatol Pract Concept*. [Review / Meta-Analysis]
Shin J (2026). [PMID: 41914837](https://pubmed.ncbi.nlm.nih.gov/41914837/). *The Journal of craniofacial surgery*. [Case Report / Case Series]
Naharro MJ (2026). [PMID: 41315892](https://pubmed.ncbi.nlm.nih.gov/41315892/). *Journal of cutaneous pathology*. [Case Report / Case Series]
Dika E (2026). [PMID: 42074195](https://pubmed.ncbi.nlm.nih.gov/42074195/). *Int J Mol Sci*. [Review / Meta-Analysis]
Lee YH (2026). [PMID: 41524681](https://pubmed.ncbi.nlm.nih.gov/41524681/). *The American Journal of dermatopathology*. [Case Report / Case Series]
Salerni G (2026). [PMID: 41912202](https://pubmed.ncbi.nlm.nih.gov/41912202/). *Dermatology practical & conceptual*. [Case Report / Case Series]
Alvi S (2026). [PMID: 30969610](https://pubmed.ncbi.nlm.nih.gov/30969610/). *Unknown Journal*. [Basic Science / Preclinical]
Sullivan DK (2026). [PMID: 41115689](https://pubmed.ncbi.nlm.nih.gov/41115689/). *Journal of cutaneous pathology*. [Review / Meta-Analysis]
Venturi F (2026). [PMID: 41891540](https://pubmed.ncbi.nlm.nih.gov/41891540/). *The Journal of dermatology*. [Diagnostic / Biomarker]
Engelsgjerd JS (2026). [PMID: 29763105](https://pubmed.ncbi.nlm.nih.gov/29763105/). *Unknown Journal*. [Basic Science / Preclinical]